RICH Statistics

Total Valuation

Laboratorios Richmond S.A.C.I.F. has a market cap or net worth of ARS 104.57 billion. The enterprise value is 213.92 billion.

Market Cap	104.57B
Enterprise Value	213.92B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Laboratorios Richmond S.A.C.I.F. has 80.75 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Shares Outstanding	80.75M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	76.96%
Owned by Institutions (%)	0.05%
Float	n/a

Valuation Ratios

The trailing PE ratio is 29.44.

PE Ratio	29.44
Forward PE	n/a
PS Ratio	2.94
PB Ratio	2.12
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.15, with an EV/FCF ratio of -84.03.

EV / Earnings	60.23
EV / Sales	6.01
EV / EBITDA	28.15
EV / EBIT	32.40
EV / FCF	-84.03

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 2.22.

Current Ratio	1.12
Quick Ratio	0.52
Debt / Equity	2.22
Debt / EBITDA	14.59
Debt / FCF	-43.50
Interest Coverage	4.68

Financial Efficiency

Return on equity (ROE) is 10.91% and return on invested capital (ROIC) is 3.99%.

Return on Equity (ROE)	10.91%
Return on Assets (ROA)	3.04%
Return on Capital (ROIC)	3.99%
Revenue Per Employee	57.39M
Profits Per Employee	5.73M
Employee Count	620
Asset Turnover	0.26
Inventory Turnover	1.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.23
52-Week Price Change	n/a
50-Day Moving Average	960.28
200-Day Moving Average	n/a
Relative Strength Index (RSI)	86.30
Average Volume (20 Days)	15,289

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Laboratorios Richmond S.A.C.I.F. had revenue of ARS 35.58 billion and earned 3.55 billion in profits. Earnings per share was 43.98.

Revenue	35.58B
Gross Profit	19.54B
Operating Income	6.59B
Pretax Income	4.89B
Net Income	3.55B
EBITDA	7.49B
EBIT	6.59B
Earnings Per Share (EPS)	43.98

Full Income Statement

Balance Sheet

The company has 1.84 billion in cash and 110.75 billion in debt, giving a net cash position of -108.92 billion or -1,348.79 per share.

Cash & Cash Equivalents	1.84B
Total Debt	110.75B
Net Cash	-108.92B
Net Cash Per Share	-1,348.79
Equity (Book Value)	49.84B
Book Value Per Share	611.85
Working Capital	4.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.43 billion and capital expenditures -3.97 billion, giving a free cash flow of -2.55 billion.

Operating Cash Flow	1.43B
Capital Expenditures	-3.97B
Free Cash Flow	-2.55B
FCF Per Share	-31.53

Full Cash Flow Statement

Margins

Gross margin is 54.91%, with operating and profit margins of 18.52% and 9.98%.

Gross Margin	54.91%
Operating Margin	18.52%
Pretax Margin	13.73%
Profit Margin	9.98%
EBITDA Margin	21.04%
EBIT Margin	18.52%
FCF Margin	-7.15%

Dividends & Yields

Laboratorios Richmond S.A.C.I.F. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.02%
Shareholder Yield	0.02%
Earnings Yield	3.40%
FCF Yield	-2.43%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Laboratorios Richmond S.A.C.I.F. has an Altman Z-Score of 0.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.56
Piotroski F-Score	n/a